Narrative: Molecular Biology

The de novo design of miniproteins and the reclassification of 'dark proteins' signify significant advancements in synthetic biology and fundamental molecular discovery. This drives demand for B2B SaaS solutions in bioinformatics, computational drug design, and advanced data management for complex biological datasets.